117 Grants (Page 1 of 5)
2023
Identification of novel therapeutic combinations for NF2 schwannomas
Angus, Steven P and Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1R01NS129769-01), $463,348USD, 2023-02-15 -- 2028-01-31
 
Indiana Pediatric Scientist Award (IPSA)
Clapp, David W and Evans Molina, Carmella
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 1K12HD111057-01), $324,000USD, 2023-02-23 -- 2027-11-30
 
Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program (PACT-D3)
Clapp, David W and Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1T32CA272370-01A1), $158,847USD, 2023-09-01 -- 2028-08-31
 
Preclinical-clinical trials collaboration to effectively advance new combination therapies for atypical neurofibroma in neurofibromatosis type 1
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1U01CA278474-01), $495,641USD, 2023-02-07 -- 2027-01-31
 
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 3R01NS128025-01S1), $44,177USD, 2023-01-01 -- 2025-12-30
2022
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1R01NS128025-01), $415,205USD, 2022-07-01 -- 2027-06-30
 
The Medical Physician Engineers, Scientists, and Clinicians Preparatory Program [MPESC-Prep]
Clapp, David W and Gaston, Benjamin
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R25HL163860-01), $160,320USD, 2022-06-01 -- 2027-05-31
2021
Basic Sciences Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E and Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007910-22), $87,201USD, 1999-07-01 -- 2025-06-30
 
Developmental and Hyperactive Ras Tumor (DHART) SPORE
Clapp, David W and SHANNON, KEVIN M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2U54CA196519-06A1), $2,198,683USD, 2015-09-01 -- 2026-08-31
 
PROJECT 1: From Neurofibroma to MPNST: Models, Biology and Translation to Clinic
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2U54CA196519-06A1-6093), $570,750USD, 2015-09-01 -- 2026-08-31
2020
Basic Sciences Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E and Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2T32HL007910-21A1), $331,293USD, 1999-07-01 -- 2025-06-30
 
F-box ubiquitin ligases destabilize neurofibromin
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS104489-03), $344,531USD, 2018-09-01 -- 2023-08-31
 
FRONTIERS IN SCIENCE CONFERENCE
Clapp, David W
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 2R13HD085773-06), $10,000USD, 2015-08-06 -- 2025-07-31
 
Indiana Medical Scientist/Engineer Training Program
Clapp, David W and Herbert, Brittney Shea
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5T32GM077229-13), $740,762USD, 2008-07-01 -- 2023-06-30
 
Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 3R01HL132921-03S1), $46,610USD, 2020-02-28 -- 2021-05-31
 
Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL132921-04), $548,019USD, 2017-08-01 -- 2021-05-31
2019
Basic Sciences Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E and Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007910-20), $193,350USD, 07/01/1999 -- 11/30/2019
 
Developmental and HyperActive Ras Tumor SPORE
Clapp, David W and Shannon, Kevin M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U54CA196519-05), $2,124,182USD, 09/01/2015 -- 08/31/2020
 
F-box ubiquitin ligases destabilize neurofibromin
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS104489-02), $344,531USD, 09/01/2018 -- 08/31/2023
 
FRONTIERS IN SCIENCE CONFERENCE
Clapp, David W
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 5R13HD085773-05), $6,000USD, 08/06/2015 -- 07/31/2020
 
Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL132921-03), $393,750USD, 08/01/2017 -- 05/31/2021
 
Project 1: Molecular and Genetic Features Across Mouse and Human Plexiform Neurofibromas to Inform Clinical Trials
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U54CA196519-05-7039), $114,840USD, 2019
2018
Basic Sciences Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E and Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007910-19), $367,696USD, 07/01/1999 -- 11/30/2019
 
Developmental and HyperActive Ras Tumor SPORE
Clapp, David W and Shannon, Kevin M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U54CA196519-04), $2,102,055USD, 09/01/2015 -- 08/31/2020
 
F-box ubiquitin ligases destabilize neurofibromin
Clapp, David W and Nalepa, Grzegorz
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1R01NS104489-01A1), $344,531USD, 09/01/2018 -- 08/31/2023